gene_banner.jpg

Dedicated to Finding a Cure for 

 

FOXG1 Syndrome 

and Many Brain Disorders

banner2.jpg

Scientists believe FOXG1 holds the key to unlock brain disorders affecting millions, including autism, schizophrenia, brain tumors and many more.

home_image_FOXG1.jpg
  • Learn why FOXG1 is an excellent candidate for gene therapy and biotech investment.
  • Find out how FOXG1 could be a viable drug target for Autism and other disorders here.
  • FOXG1 Research Group is supported by the world-renowned BLACKSWAN Foundation in Switzerland.
  • We are funding leading neuroscientists and pioneering ground-breaking research on brain disorders.

FOXG1 is one of the first and most fundamental genes formed during human development. 


 
 

Path To A Cure

Scientists believe a cure is possible. See our  Path To A Cure here.

Research Projects

See the research we have underway! 

Scientists

For Scientists: see our grant application process.


Scientific Advisory Board

  Orrin Devinsky,   MD  Neurosurgeon, NYU Langone, Chief of Service, NYU Epilepsy   READ BIO

Orrin Devinsky, MD Neurosurgeon, NYU Langone, Chief of Service, NYU Epilepsy
READ BIO

  Robin Kleiman, Ph.D  Senior Director, Biogen Research Associate, Boston Children’s Hospital   READ BIO   

Robin Kleiman, Ph.D Senior Director, Biogen Research Associate, Boston Children’s Hospital
READ BIO 

  Kiran Reddy, MD  CEO, Praxis Precision Medicines, Former Partner, Clarus Ventures   READ BIO

Kiran Reddy, MD
CEO, Praxis Precision Medicines, Former Partner, Clarus Ventures
READ BIO

  Aris Economides, PhD  Vice President of Research, Regeneron Pharmaceuticals   READ BIO

Aris Economides, PhD
Vice President of Research, Regeneron Pharmaceuticals
READ BIO

  Steven Gray, PhD  Scientist, Gene Therapy Center at UNC School of Medicine   READ BIO

Steven Gray, PhD
Scientist, Gene Therapy Center at UNC School of Medicine
READ BIO

  Ingrid Scheffer, MD, PhD  Neurologist and Senior Research Fellow, Florey Institute of Neuroscience and Mental Health   READ BIO

Ingrid Scheffer, MD, PhD
Neurologist and Senior Research Fellow, Florey Institute of Neuroscience and Mental Health
READ BIO

  Elli Brimble, MSc, MS, CGC  Geneticist, Lucille Packard Children’s Hospital at Stanford   READ BIO

Elli Brimble, MSc, MS, CGC
Geneticist, Lucille Packard Children’s Hospital at Stanford
READ BIO

  Neil Kumar, PhD  CEO, BridgeBio Pharma, Former Principal, Third Rock Ventures   READ BIO

Neil Kumar, PhD
CEO, BridgeBio Pharma, Former Principal, Third Rock Ventures
READ BIO

  Heather Olson, MD, MS  Neurologist, Boston Children's; Neurology Instructor, Harvard Medical   READ BIO

Heather Olson, MD, MS
Neurologist, Boston Children's; Neurology Instructor, Harvard Medical
READ BIO

  Xilma Ortiz-Gonzalez, MD, PhD  Pediatric Neurologist, CHOP, Neurology Instructor, University of Pennsylva   READ BIO

Xilma Ortiz-Gonzalez, MD, PhD
Pediatric Neurologist, CHOP, Neurology Instructor, University of Pennsylva
READ BIO

  Mary Jones, MD  Pediatrician, Head, Katie's RETT Clinic at UCSF Oakland   READ BIO

Mary Jones, MD
Pediatrician, Head, Katie's RETT Clinic at UCSF Oakland
READ BIO

  Gordon Fishell, PhD  Scientist, Broad Institute; Professor, Harvard Medical School   READ BIO

Gordon Fishell, PhD
Scientist, Broad Institute; Professor, Harvard Medical School
READ BIO

  Hourinaz Behesti, PhD  Developmental Neurobiologist, Rockefeller University   READ BIO

Hourinaz Behesti, PhD
Developmental Neurobiologist, Rockefeller University
READ BIO

  Toni Cathomen, PhD    Director, Institute for Cell and Gene Therapy, University of Freiburg   READ BIO

Toni Cathomen, PhD  
Director, Institute for Cell and Gene Therapy, University of Freiburg
READ BIO

  Ritu Lal, PhD    Clinical Pharmacology Consultant   READ BIO

Ritu Lal, PhD  
Clinical Pharmacology Consultant
READ BIO